Evidence mapPaperPMID 42437658Full record

ReviewCell proliferation2026

Lysine l-Lactylation: Bridging Metabolism, Chromatin and Disease.

Anoosha Malik, Muhammad Dilawar, Junguang Liao, Jie Zheng, Qitao Qian, Ming Xu, Sisi Lin, Xiaobo Zhu, Qiuwei Ge, Limin Jin and 1 more

Abstract readReview
In one paragraph

Review in Cell proliferation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anoosha MalikDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Muhammad DilawarDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Junguang LiaoDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Jie ZhengDepartment of Orthopaedics, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China.
Qitao QianDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Ming XuDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Sisi LinDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Xiaobo ZhuDepartment of Orthopaedic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Qiuwei GeClinical Laboratory, Zhejiang Rehabilitation Medical Center, Hangzhou, Zhejiang, China.
Limin JinClinical Laboratory, The Second Hospital of Jiaxing, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
Guiqian ChenDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.ORCID https://orcid.org/0000-0001-6452-440X

Funding

Fundamental Research Funds of Zhejiang Sci-Tech University 26042139-YNational Natural Science Foundation of China 81400489National Natural Science Foundation of China 82571024Zhejiang Provincial Natural Science Foundation of China LZ23H140001
6 · The paper itself

Abstract

Lysine L-lactylation (K

Indexed as

ChromatinLysineProtein Processing, Post-TranslationalAnimalsHistonesHumansNeurodegenerative DiseasesChromatinHistonesLysinelactatelysine lactylationpost‐translational modification (PTM)writer–eraser–reader proteins

Identifiers

PMID42437658
PMCPMC13356951

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.